Cited by 1,271Alcohol Consumption and Health EffectsLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

The DOI matches its Crossref record; 242 of the 244 references it cites were found in a registry or an index.

Alcoholic liver disease

Seitz, Helmut K., Bataller, Ramon, Cortez-Pinto, Helena, Gao, Bin, Gual, Antoni, Lackner, Carolin, Mathurin, Philippe, Mueller, Sebastian, Szabo, Gyongyi, Tsukamoto, Hidekazu·2018·Nature Reviews Disease Primers

DOI 10.1038/s41572-018-0014-7

Open this paper in CoChat — free account

Abstract

Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease worldwide. ALD can progress from alcoholic fatty liver (AFL) to alcoholic steatohepatitis (ASH), which is characterized by hepatic inflammation. Chronic ASH can eventually lead to fibrosis and cirrhosis and in some cases hepatocellular cancer (HCC). In addition, severe ASH (with or without cirrhosis) can lead to alcoholic hepatitis, which is an acute clinical presentation of ALD that is associated with liver failure and high mortality. Most individuals consuming >40 g of alcohol per day develop AFL; however, only a subset of individuals will develop more advanced disease. Genetic, epigenetic and non-genetic factors might explain the considerable interindividual variation in ALD phenotype. The pathogenesis of ALD includes hepatic steatosis, oxidative stress, acetaldehyde-mediated toxicity and cytokine and chemokine-induced inflammation. Diagnosis of ALD involves assessing patients for alcohol use disorder and signs of advanced liver disease. The degree of AFL and liver fibrosis can be determined by ultrasonography, transient elastography, MRI, measurement of serum biomarkers and liver biopsy histology. Alcohol abstinence achieved by psychosomatic intervention is the best treatment for all stages of ALD. In the case of advanced disease such as cirrhosis or HCC, liver transplantation may be required. Thus, new therapies are urgently needed.

Integrity signals

Registry

Crossref · 10.1038/s41572-018-0014-7

Cites

242 of 242 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells
Chen, C., Tsukamoto, H., Liu, J.-C., Kashiwabara, C., Feldman, D. E., Sher, L. S., Dooley, S., French, S. W., Mishra, L., Petrovic, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65859 · Cited by 161
Self-citation
Retracted
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
The AUDIT Alcohol Consumption Questions (AUDIT-C)<subtitle>An Effective Brief Screening Test for Problem Drinking</subtitle>
Bush, K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1789 · Cited by 6,196
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2017) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,107
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219

Show all 244 references

Research works printed but not linked: 4

Pone, E. J. Toll-like receptors. Signal. Pathways Liver Diseases 1390, 149–159 (2016).
French, S. W. & Bardag-Gorce, F. in Signaling Pathways in Liver Diseases (eds Dufour, J.-F. et al.) 377–389 (Springer, 2005).
Thiele, M. et al. Controlled attenuation parameter and alcoholic hepatic steatosis: diagnostic accuracy and role of alcohol detoxification. J. Hepatol. 68, 1025–1032 (2018). · DOI
[No authors listed.]. Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1, 707–711 (1981).

Sorted by citations

Items 501–600 of 999

Non-invasive Biomarkers of Liver Inflammation and Cell Death in Response to Alcohol Detoxification
Neuman, M. G., Mueller, J. H., & Mueller, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.678118 · Cited by 15
Self-citation
Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration
Warner, J. B., Hardesty, J., Song, Y., Sun, R., Deng, Z., Xu, R., Yin, X., Zhang, X., McClain, C. J., Warner, D. R., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.711590 · Cited by 14
Baicalin ameliorates alcohol-induced hepatic steatosis by suppressing SREBP1c elicited PNPLA3 competitive binding to ATGL
Li, P., Chen, Y., Ke, X., Zhang, R., Zuo, L., Wang, M., Chen, Z., Luo, X., & Wang, J. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109236 · Cited by 15
Multifaceted involvements of Paneth cells in various diseases within intestine and systemically
Cui, C., Wang, X., Li, L., Wei, H., & Peng, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1115552 · Cited by 17
Mesencephalic astrocyte-derived neurotrophic factor alleviates alcohol induced hepatic steatosis via activating Stat3-mediated autophagy
Zhang, G., Liu, Q., Li, Y., Huang, C., Zhou, J., Zhao, Y., Wu, T., Tang, Q., Li, R., Zhang, Z., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.123 · Cited by 15
Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study
Ocskay, K., Juhász, M. F., Farkas, N., Zádori, N., Szakó, L., Szakács, Z., Szentesi, A., Erőss, B. M., Miklós, E., Zemplenyi, A. T., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-050821 · Cited by 15
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Chen, P., Li, Y., Dai, Y., Wang, Z., Zhou, Y., Wang, Y., & Li, G. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s450460 · Cited by 14
Liver transplantation for alcohol-associated liver disease
Simonetto, D. A., Winder, G. S., Connor, A. A., & Terrault, N. A. (2024) · Hepatology · doi:10.1097/hep.0000000000000978 · Cited by 14
Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescence
Rodrigo‐Torres, D., Kilpatrick, A. M., Ferreira-González, S., Aird, R. E., Atkinson, S. R., Gadd, V. L., Man, T. Y., Tyson, L. D., Dhondalay, G. K., Vergis, N., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334094 · Cited by 17
Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases
Xiang, H., Wu, Z., Wang, J., & Wu, T. (2021) · Journal of Cancer · doi:10.7150/jca.57951 · Cited by 14
NADH and NRH as potential dietary supplements or pharmacological agents for early liver injury caused by acute alcohol exposure
Wu, K., Li, J., Zhou, X., Zhou, F. Y., Tang, S., Yi, L., Wu, Y., & Tian, S. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104852 · Cited by 14
Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice
Li, L., Bi, Y., Diao, S., Li, X., Yuan, T., Xu, T., Huang, C., & Li, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115032 · Cited by 14
A machine learning-based classification of adult-onset diabetes identifies patients at risk of liver-related complications
Sanchez, L. O., Zhan, C.-Y., Cauduro, C. G. D. S., Crenier, L., Njimi, H., Englebert, G., Putignano, A., Lepida, A., Degré, D., Boon, N., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100791 · Cited by 16
Saturated fatty acids synergizes cadmium to induce macrophages M1 polarization and hepatic inflammation
Zhu, Y., Chai, X., Zhao, Y., Feng, Q., Dong, R., Shi, M., Jiang, Z., Zhao, Y., Peng, J., Tian, Y., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115040 · Cited by 14
The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies
Hizo, G. H., & Rampelotto, P. H. (2023) · Microorganisms · doi:10.3390/microorganisms11122999 · Cited by 14
Hepatoprotective effects of peach gum polysaccharides against alcoholic liver injury: moderation of oxidative stress and promotion of lipid metabolism
Zhou, B., Liu, P., Yao, X., Cao, H., Zhu, H., Wang, Q., Liu, Y., Fang, M., Wu, Y., & Gong, Z. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1325450 · Cited by 14
Hydroethanolic extract of Gentiana kurroo Royle rhizome ameliorates ethanol-induced liver injury by reducing oxidative stress, inflammation and fibrogenesis in rats
Choubey, P., Sharma, V., Joshi, R., Upadhyaya, A., Kumar, D., & Patial, V. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117866 · Cited by 14
Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
Malik, A., Malik, M., & Qureshi, S. (2024) · Canadian Liver Journal · doi:10.3138/canlivj-2023-0021 · Cited by 15
Platelets in Alcohol-Associated Liver Disease: Interaction With Neutrophils
Wang, J., Wang, X., Peng, H., Dong, Z., Liangpunsakul, S., Zuo, L., & Wang, H. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.03.001 · Cited by 15
Bacillus coagulans regulates gut microbiota and ameliorates the alcoholic-associated liver disease in mice
Liu, Z., Liu, T., Zhang, Z., & Fan, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1337185 · Cited by 14
Context-dependent role of sirtuin 2 in inflammation
Sola-Sevilla, N., Garmendia-Berges, M., Mera-Delgado, M., & Puerta, E. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-02063 · Cited by 18
Cyanidin-3-O-glucoside alleviates ethanol-induced liver injury by promoting mitophagy in a Gao-binge mouse model of alcohol-associated liver disease
He, Q., Yin, Z., Chen, Y., Wu, Y., Pan, D., Cui, Y., Zhang, Z., Ma, H., Li, X., Shen, C., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167259 · Cited by 16
Investigating the Interplay of Toxic Metals and Essential Elements in Liver Disease
Adetunji, A. G., & Obeng-Gyasi, E. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21060762 · Cited by 17
A Butyrate-Yielding Dietary Supplement Prevents Acute Alcoholic Liver Injury by Modulating Nrf2-Mediated Hepatic Oxidative Stress and Gut Microbiota
Xu, Q., Guo, M., Wang, H., Liu, H., Wei, Y., Wang, X. D., Mackay, C. R., & Wang, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179420 · Cited by 15
The Changing Demographics and Epidemiology of Hepatocellular Carcinoma
Gujarathi, R., Klein, J. A., Liao, C., & Pillai, A. A. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.08.001 · Cited by 15
Antioxidative Therapy of Alcoholic Liver Injury by Amorphous Two‐Dimensional Cobalt Hydroxide Nanocatalyst
Jiang, D., Yang, B., & Shi, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202412031 · Cited by 14
Chronic systemic inflammation predicts long-term mortality among patients with fatty liver disease: Data from the National Health and Nutrition Examination Survey 2007–2018
Pan, X., Lv, J., Liu, M., Li, Y., Zhang, Y., Zhang, R., Liu, J., Sun, C., & Guo, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312877 · Cited by 14
Alpinetin Exhibits Antioxidant and Anti-Inflammatory Effects in C57BL/6 Mice with Alcoholic Liver Disease Induced by the Lieber–DeCarli Ethanol Liquid Diet
Radosavljević, T., Branković, M., Djuretić, J., Grujić-Milanović, J., Kovačić, M., Jevtić, J., Stanković, S., Samardžić, J., Vučević, D., & Jakovljević, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010086 · Cited by 14
Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis
Huang, T., Zhou, M.-Y., Zou, G.-L., Hu, R.-H., Han, L., Zhang, Q.-X., & Zhao, X.-K. (2025) · Scientific Reports · doi:10.1038/s41598-025-88538-8 · Cited by 14
Evaluation of the hepatoprotective effect of Yigan mingmu oral liquid against acute alcohol-induced liver injury in rats
Mo, Q., Zhou, G., Xie, B., Ma, B., Zang, X., Chen, Y., Cheng, L., Zhou, J. H., & Wang, Y. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2817-9 · Cited by 14
Intestinal ELF4 Deletion Exacerbates Alcoholic Liver Disease by Disrupting Gut Homeostasis
Liu, T., Yu, H., Zhang, Z., Xie, Y., Yang, L., & You, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094825 · Cited by 14
Metformin administration is associated with enhanced response to transarterial chemoembolization for hepatocellular carcinoma in type 2 diabetes patients
Jung, W. J., Jang, S., Choi, W. J., Park, J., Choi, G. H., Jang, E. S., Jeong, S., Choi, W. S., Lee, J. H., Yoon, C. J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18341-2 · Cited by 14
Relationship between alcohol consumption and adverse childhood experiences in college students–A cross-sectional study
Sulejova, K. K., Líška, D., Liptáková, E., Szántová, M., Patarák, M., Koller, T., Baťalík, L., Makara, M., & Skladaný, Ľ. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1004651 · Cited by 15
Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
Thorhauge, K. H., Thiele, M. S., Detlefsen, S., Rasmussen, D. N., Johansen, S., Madsen, B. S., Antonsen, S., Rasmussen, L. M., Lindvig, K. P., & Krag, A. A. (2022) · Hepatology Communications · doi:10.1002/hep4.2075 · Cited by 14
Chronic alcohol intake regulates expression of SARS‐CoV2 infection‐relevant genes in an organ‐specific manner
Friske, M. M., Giannone, F., Senger, M., Seitz, R., Hansson, A. C., & Spanagel, R. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14981 · Cited by 15
Mogroside V prevents ethanol-induced hangover and liver damage by reducing oxidative stress, steatosis and inflammation
Ai, R., Tian, M., Sun, J., He, S., Cui, Z., Yang, Y., Hou, X., Zhao, Y., Dou, T., Chen, X., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151912 · Cited by 13
Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets
Ramírez-Mejía, M. M., Ponciano‐Rodríguez, G., & Méndez‐Sánchez, N. (2025) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103335 · Cited by 15
Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities
Zhou, H., Huang, Y., Chen, C., Song, M., & Hylemon, P. B. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100120 · Cited by 17
Functional metabolomics revealed functional metabolic-characteristics of chronic hepatitis that is significantly differentiated from acute hepatitis in mice
Wang, T., Hu, L., Lu, J., Xiao, M., Liu, J., Xia, H., & Lu, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106248 · Cited by 13
Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis
Melkebeke, L. V., Broekhoven, A. G. C., Ostyn, T., Korf, H., Coenraad, M. J., Vangoitsenhoven, R., der Schueren, B. V., Lannoo, M., van Malenstein, H., Roskams, T., et al. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06386-1 · Cited by 13
The Ethanolic Extract of Lindera aggregata Modulates Gut Microbiota Dysbiosis and Alleviates Ethanol‐Induced Acute Liver Inflammation and Oxidative Stress SIRT1/Nrf2/NF‐ κ B Pathway
Zhao, X., Tan, M., He, Y., Pan, Y., Fan, X., Ye, L., Liu, L., & Fu, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6256450 · Cited by 13
Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice
Dorochow, E., Kraus, N., Chenaux-Repond, N., Pierre, S. C., Kolbinger, A., Geißlinger, G., Ortiz, C., Welsch, C., Trebicka, J., Gurke, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210351 · Cited by 13
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study
Wu, M., Qin, S., Tan, C., Li, S., Xie, O., & Wan, X. (2023) · BMC Medicine · doi:10.1186/s12916-023-02984-7 · Cited by 13
Synergistic Protective Effect of Fermented Schizandrae Fructus Pomace and Hoveniae Semen cum Fructus Extracts Mixture in the Ethanol-Induced Hepatotoxicity
Jegal, K.-H., Park, H., Choi, B., Kim, J. K., & Ku, S. (2023) · Antioxidants · doi:10.3390/antiox12081602 · Cited by 13
Larsucosterol: endogenous epigenetic regulator for treating chronic and acute liver diseases
Wang, Y., Ren, J., & Ren, S. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00406.2023 · Cited by 14
Progress, application and challenges of liver organoids
Sang, C., Lin, J., Ji, S., & Gao, Q. (2024) · Clinical Cancer Bulletin · doi:10.1007/s44272-024-00012-0 · Cited by 14
GSDMD induces hepatocyte pyroptosis to trigger alcoholic hepatitis through modulating mitochondrial dysfunction
Xie, Y., Wang, Z., Song, G., Ma, H., & Feng, B. (2024) · Cell Division · doi:10.1186/s13008-024-00114-0 · Cited by 13
Alcohol-related diseases: from metabolism to the main effect on the body
Caputo, F., Lungaro, L., Guarino, M., Costanzini, A., Caio, G., Testino, G., & GIORGIO, R. D. (2024) · Minerva Medica · doi:10.23736/s0026-4806.24.09355-8 · Cited by 14
Polygala fallax Hemsl polysaccharides alleviated alcoholic fatty liver disease by modifying lipid metabolism via AMPK
Lv, R., Cao, H., Zhong, M., Wu, J., Lin, S., Li, B., Chen, D., Zhang, Z., Zhang, K., & Gao, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135565 · Cited by 13
Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model
Maeda, H., Minayoshi, Y., Ichimizu, S., Mizuta, Y., Nagasaki, T., Matsusaka, K., Oshiro, S., Oniki, K., Saruwatari, J., Ishima, Y., et al. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00599 · Cited by 13
A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice
Silva, J., Carry, E., Chen, X., Zhang, J., Liang, J., Roberge, J. Y., & Davies, D. L. (2021) · Molecules · doi:10.3390/molecules26061791 · Cited by 13
Alcoholic Liver Disease
Higuera‐de‐la‐Tijera, F., Lira-Vera, J. E., Morales-Gutiérrez, O., Martínez‐Castillo, M., Medina‐Ávila, Z., Servín-Caamaño, A., Pérez-Hernández, J. L., & Gutiérrez‐Reyes, G. (2022) · Clinical Liver Disease · doi:10.1002/cld.1164 · Cited by 13
Non-invasive assessment of liver fibrosis in alcoholic liver disease
Husain, A., Chiwhane, A. A., & Kirnake, V. (2020) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2020.95739 · Cited by 13
Gut microbiota and HMGB1/NLRP3/GSDMD inflammasome-dependent pyroptosis: mechanisms by physcion ameliorates alcoholic liver fibrosis
Bai, T., Guo, H., Wang, F., Kang, Y.-Y., Zhang, H., Dong, L., & Yang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1532590 · Cited by 12
Chronic alcohol intake disrupts cytochrome P450 enzyme activity in alcoholic fatty liver disease: insights into metabolic alterations and therapeutic targets
Zhu, Q., Xie, X., Fang, L., Huang, C., & Li, J. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1509785 · Cited by 12
Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary
Adams, L. A., Kemp, W. W., Muller, K., Powell, E. E., Roberts, S. K., Bertot, L. C., Best, S., Deed, G., Emery, J. D., HOCKING, S. L., et al. (2025) · The Medical Journal of Australia · doi:10.5694/mja2.70008 · Cited by 12
Formononetin mitigates alcoholic liver disease by restoring ALDH2 function and inducing ERK1/2–Nrf2 antioxidant signaling
Ma, Z., Sun, J., Guo, C., Ju, J., Qiao, Y., Niu, J., Zhou, L., Ren, Q., Wu, Q., Wen, A., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157408 · Cited by 12
Qinggan Huoxue Recipe attenuates Alcoholic Liver Disease by suppressing PI3K/AKT signaling pathway based on network pharmacology
Wang, J., Lu, Y., Zhang, C., Shuxia, T., Xiang, H., Ding, P., Chen, J., Ji, G., & Wu, T. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.80329 · Cited by 12
Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity
Calzadilla, N., Zilberstein, N., Hanscom, M. H., Rashdan, H., Chacra, W., Gill, R. K., & Alrefai, W. A. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.10.006 · Cited by 12
A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer
Alarcón‐Sánchez, B. R., Idelfonso-García, O. G., Guerrero‐Escalera, D., Piña‐Vázquez, C., de Anda‐Jáuregui, G., Pérez-Hernández, J. L., de la Garza, M., García‐Sierra, F., Sánchez-Pérez, Y., Baltiérrez‐Hoyos, R., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116209 · Cited by 14
Metabolic Dysfunction-Associated Steatohepatitis Detected by Neutrophilic Crown-Like Structures in Morbidly Obese Patients: A Multicenter and Clinicopathological Study
Fan, M., Song, E., Zhang, Y., Zhang, P., Huang, B., Yan, K., Yang, W., Chakrabarti, S., Mahajan, H., Yan, S., et al. (2024) · Research · doi:10.34133/research.0382 · Cited by 13
Restoring energy metabolism by NAD + supplement prevents alcohol‐induced liver injury and boosts liver regeneration
Liu, Y., Cheng, C., Gao, H., Zhu, X., He, X., Zhou, M., Gao, Y., Lu, Y., Song, X., Xiao, X., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4159 · Cited by 14
Dose‐response analysis between alcohol consumption and psoriasis: A systematic review and meta‐analysis
Choi, J., Han, I., Min, J., Yun, J., Kim, B., Shin, K., Kim, K., & Kim, Y. H. (2024) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15380 · Cited by 12
Metallofullerenol alleviates alcoholic liver damage via ROS clearance under static magnetic and electric fields
Wang, H., Zhao, J., Ji, S., Liu, T., Cheng, Z., Huang, Z., Zang, Y., Chen, J., Zhang, J., & Ding, Z. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.003 · Cited by 12
Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications
AbouSamra, M. M. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2377085 · Cited by 15
Low to moderate ethanol exposure reduces astrocyte-induced neuroinflammatory signaling and cognitive decline in presymptomatic APP/PS1 mice
Kang, S., Lee, J., Ali, D. N., Choi, S. H., Nesbitt, J. J., Min, H.-K. P., Trushina, E. V., & Choi, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-75202-w · Cited by 16
Enteromorpha prolifera Polysaccharide Alleviates Acute Alcoholic Liver Injury in C57 BL/6 Mice through the Gut–Liver Axis and NF-κB Pathway
Yan, T., Sun, J., Zhang, Y., Wen, C., & Yang, J. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c05262 · Cited by 12
Causal relationships between the gut microbiota, inflammatory cytokines, and alcoholic liver disease: a Mendelian randomization analysis
Li, S., Zhou, C., Liu, T., Zhang, L., Liu, S., Zhao, Q., Liu, J., & Zhao, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1442603 · Cited by 13
Ellagic Acid Protects against Alcohol-Related Liver Disease by Modulating the Hepatic Circadian Rhythm Signaling through the Gut Microbiota–NPAS2 Axis
Zhang, H., Zhou, W., Gao, P., Li, Z., Li, C., Li, J., Bian, J., Gong, L., He, C., Han, L., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c06992 · Cited by 13
Visium spatial transcriptomics and proteomics identifies novel hepatic cell populations and transcriptomic signatures of alcohol‐associated hepatitis
Gripshover, T. C., Treves, R. S., Rouchka, E. C., Chariker, J. H., Zheng, S., Hudson, E., Smith, M. L., Singal, A. K., McClain, C. J., & Hardesty, J. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15494 · Cited by 12
Nicotinamide riboside targets mitochondrial unfolded protein response to reduce alcohol‐induced damage in K upffer cells
Lee, J., Woo, H., Kang, H., Park, Y., & Lee, J. (2024) · The Journal of Pathology · doi:10.1002/path.6372 · Cited by 13
Cigarette smoking and alcohol-related liver disease
Lin, H., Zhang, J., Li, M.-X., Hou, H., Wang, H., & Huang, Y. (2024) · Liver Research · doi:10.1016/j.livres.2024.12.002 · Cited by 12
Vine tea (Ampelopsis grossedentata) ameliorates chronic alcohol-induced hepatic steatosis, oxidative stress, and inflammation via YTHDF2/PGC-1α/SIRT3 axis
Luo, Q., Qiu, J., Chen, M., Yang, N., Li, X., Huang, S., Ma, Q., Li, Z., Lou, D., Du, Y., et al. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116321 · Cited by 12
Decreased Lysosomal Polarity during Acute Alcoholic Liver Injury Revealed by a Near-Infrared Fluorescent Probe
Dai, B., Jiang, S., Wang, W., Li, Z., & Feng, G. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02887 · Cited by 12
Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease
Fadriquela, A., Kim, C.-S., Lee, K., Kang, S. H., & Lee, J. (2021) · Alcohol · doi:10.1016/j.alcohol.2021.10.002 · Cited by 12
Role of cell-free network communication in alcohol-associated disorders and liver metastasis
Kuracha, M. R., Thomas, P., Tobi, M., & McVicker, B. L. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i41.7080 · Cited by 11
Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma
Yao, S., Chen, W., Zuo, H., Bi, Z., Zhang, X., Pang, L., Jing, Y., Yin, X., & Cheng, H. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10178-0 · Cited by 12
Comparative study between the effects of aged and fresh Chinese baijiu on gut microbiota and host metabolism
Fang, C., Lü, W., Liu, Q., Chen, Y. Q., Jia, W. P., & Xu, Y. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101859 · Cited by 11
γ‐Glutamylcysteine alleviates ethanol‐induced hepatotoxicity via suppressing oxidative stress, apoptosis, and inflammation
Liu, J., Lü, S., Zhang, X., Zhou, J., Yan, X., Liu, H., Liang, J., Luo, L., Zhou, D., & Yin, Z. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14318 · Cited by 12
Study on the hepatoprotective effect of Sporidiobolus pararoseus polysaccharides under the “gut microbiome-amino acids metabolism” network
Liu, C., Hua, H., Guo, Y., Qian, H., Liu, J., & Cheng, Y. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101928 · Cited by 12
CD73 aggravates alcohol-related liver fibrosis by promoting autophagy mediated activation of hepatic stellate cells through AMPK/AKT/mTOR signaling pathway
Wu, X., Liu, X., Liu, Z., Xia, G., Zhu, H., Zhang, M.-D., Wu, B., & Lv, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109229 · Cited by 13
Periostin Protects Against Alcohol-related Liver Disease by Activating Autophagy by Interacting With Protein Disulfide Isomerase
Zhang, Y., Jin, J., Wu, H., Huang, J., Ye, S., Qiu, J., Ouyang, G., Wu, T., Liu, F., & Liu, Y. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.005 · Cited by 12
Ethanol Disrupts Hormone-Induced Calcium Signaling in Liver
Gaspers, L. D., Thomas, A. P., Hoek, J. B., & Bartlett, P. J. (2021) · Function · doi:10.1093/function/zqab002 · Cited by 12
Pre-Exposure to TiO2-NPs Aggravates Alcohol-Related Liver Injury by Inducing Intestinal Barrier Damage in Mice
Liu, S., Zhao, Y., Liu, Y., Tang, Y., Xu, X., Wang, M., Tao, X., & Xu, H. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab127 · Cited by 12
Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy: A Multicenter Observational Study
Novo‐Veleiro, I., Flores, J. H., Rosón-Hernández, B., García, M., Muga, R., Fernández-Solá, J., Martín-González, M.-C., Seco-Hernández, E., Suárez-Cuervo, C., Mateos-Díaz, A.-M., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109186 · Cited by 12
The Role of Oxidative Inactivation of Phosphatase PTEN and TCPTP in Fatty Liver Disease
Huu, T. N., Park, J., Zhang, Y., Thanh, H. D., Park, I., Choi, J. M., Yoon, H. J., Park, S. C., Woo, H. A., & Lee, S.-R. (2023) · Antioxidants · doi:10.3390/antiox12010120 · Cited by 12
A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver diseasePreprint
Niu, L., Thiele, M. S., Geyer, P. E., Rasmussen, D. N., Webel, H. E., Santos, A., Gupta, R., Meier, F., Strauss, M. T., Kjærgaard, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.16.337592 · Cited by 12
Targeting Polymeric Nanoparticles to Specific Cell Populations in the Liver
Harkins, L., Vilarinho, S., & Saltzman, W. M. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00712 · Cited by 11
Obstructive sleep apnea is ralated to metabolic dysfunction associated steatotic liver disease in type 2 diabetes mellitus
Jia, X., Zou, C., Lu, N., Lu, Q., & Xie, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-09985-x · Cited by 11
Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease
Gao, B., Zhu, Y., Gao, N., Shen, W., Stärkel, P., & Schnabl, B. (2021) · Metabolites · doi:10.3390/metabo11110766 · Cited by 11
Self-citation
Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease
Martínez‐Castillo, M., Altamirano-Mendoza, I., Sánchez-Valle, S., García-Islas, L., Sánchez-Barragán, M., Hernandez-Santillan, M., Hernández-Barragán, A., Pérez-Hernández, J. L., la Tijera, F. H., & Gutiérrez‐Reyes, G. (2023) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2023.03.003 · Cited by 11
Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking
Tan, Y., Zhang, F., Fan, X., Lu, S., Liu, Y., Wu, Z., Huang, Z., Wu, C., Cheng, G., Li, B., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00759-z · Cited by 11
Poria cocos polysaccharides improve alcoholic liver disease by interfering with ferroptosis through NRF2 regulation
Zhou, X.-Y., Wang, J., & Zhou, S.-F. (2024) · Aging · doi:10.18632/aging.205693 · Cited by 24
Mesenchymal stem/stromal cells armored by FGF21 ameliorate alcohol-induced liver injury through modulating polarization of macrophages
Huai, Q., Zhu, C., Zhang, X., Dai, H., Li, X., & Wang, H. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000410 · Cited by 11
Maslinic acid alleviates alcoholic liver injury in mice and regulates intestinal microbiota via the gut–liver axis
Su, J., Dai, Y., Wu, X., Zhou, X., Fang, X., Ge, X., & Zhao, L. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13624 · Cited by 12
Mitigative Effect of Graphene Oxide Nanoparticles in Maintaining Gut–Liver Homeostasis against Alcohol Injury
Aghara, H., Chadha, P., & Mandal, P. (2024) · Gastroenterology Insights · doi:10.3390/gastroent15030042 · Cited by 11
Inhibition of ethanol-induced eNAMPT secretion attenuates liver ferroptosis through BAT-Liver communication
Zhou, Y., Pang, N., Li, W., Li, Q., Luo, J., Gu, Y., Hu, Q., Ding, Y., Sun, Y., Pan, J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103274 · Cited by 11
Nobiletin protects against alcohol-induced mitochondrial dysfunction and liver injury by regulating the hepatic NRF1-TFAM signaling pathway
Lü, D., Huang, A., Tong, X.-Q., Zhang, X., Li, S., & Yu, X. (2024) · Redox Report · doi:10.1080/13510002.2024.2395779 · Cited by 11
Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD)
Sánchez, V., Baumann, A., Kromm, F., Yergaliyev, T., Brandt, A., Scholda, J., Kopp, F. B., Camarinha‐Silva, A., & Bergheim, I. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00950-4 · Cited by 11
Associations of alcohol with the human gut microbiome and prospective health outcomes in the FINRISK 2002 cohort
Koponen, K., McDonald, D. T., Jousilahti, P., Méric, G., Inouye, M., Lahti, L., Niiranen, T., Männistö, S., Havulinna, A. S., Knight, R. D., et al. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03668-z · Cited by 11

Authors: Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H.
Affiliations: Heidelberg University (DE)
University of Pittsburgh (US)
National Institutes of Health (US)
Hospital Clínic de Barcelona (ES)
Medical University of Graz (AT)
Inserm (FR)
University of Southern California (US)
ORCID: Bataller, Ramon
Gao, Bin
Gual, Antoni
Lackner, Carolin
Mathurin, Philippe
Mueller, Sebastian
Tsukamoto, Hidekazu
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2018-08-16
Volume: 4
Issue: 1
Pages: 16-16
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-018-0014-7
OpenAlex: W4210980460
Cited by: 1,271
References: 244
Citations by year: 2026: 126 · 2025: 200 · 2024: 249 · 2023: 230 · 2022: 176 · 2021: 145 · 2020: 75 · 2019: 57 · 2018: 9
FWCI: 10.57
Type: journal article
Language: en
Update notices: correction (2018-08-28)
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Funders: U.S. Department of Veterans Affairs (IK6BX004205, I01 BX001991)
National Institute on Alcohol Abuse and Alcoholism (R01AA011576)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords: alcoholic liver disease, alcoholic fatty liver, alcoholic steatohepatitis, alcoholic hepatitis, liver cirrhosis, hepatocellular carcinoma, liver fibrosis, hepatic steatosis, oxidative stress, acetaldehyde toxicity, liver inflammation, alcoholism, liver fibrosis diagnosis, serum biomarkers, alcohol abstinence, liver transplantation
MeSH terms: Global Burden of Disease, Alcohol Drinking, Fatty Liver, Alcoholic, Humans, Liver Diseases, Alcoholic, Liver Neoplasms, Quality of Life, Liver Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alcoholic liver disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks